PRTK - パラテック・ファ―マシュ―ティカルズ (Paratek Pharmaceuticals Inc. )

PRTKのニュース

   Insider Selling: Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Chairman Sells $127,442.15 in Stock  2020/12/18 14:04:41 Watchlist News
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Chairman Michael Bigham sold 18,337 shares of the company’s stock in a transaction on Friday, December 11th. The shares were sold at an average price of $6.95, for a total transaction of $127,442.15. Following the transaction, the chairman now owns 572,580 shares of the company’s stock, valued at $3,979,431. The transaction […]
   Insider Selling: Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Chairman Sells $174,882.73 in Stock  2020/12/18 12:14:41 Watchlist News
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Chairman Michael Bigham sold 26,063 shares of Paratek Pharmaceuticals stock in a transaction that occurred on Monday, December 14th. The shares were sold at an average price of $6.71, for a total transaction of $174,882.73. Following the sale, the chairman now directly owns 572,580 shares in the company, valued at approximately […]
   William M. Haskel Sells 4,814 Shares of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Stock  2020/12/16 12:38:41 Watchlist News
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) General Counsel William M. Haskel sold 4,814 shares of the business’s stock in a transaction dated Friday, December 11th. The stock was sold at an average price of $6.95, for a total transaction of $33,457.30. Following the sale, the general counsel now owns 210,109 shares in the company, valued at $1,460,257.55. […]
   Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Insider Sells $62,862.75 in Stock  2020/12/16 12:38:41 Watchlist News
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) insider Adam Woodrow sold 9,045 shares of Paratek Pharmaceuticals stock in a transaction on Friday, December 11th. The shares were sold at an average price of $6.95, for a total transaction of $62,862.75. Following the completion of the sale, the insider now directly owns 284,128 shares in the company, valued at […]
   Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Insider Adam Woodrow Sells 12,855 Shares  2020/12/16 12:38:41 Watchlist News
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) insider Adam Woodrow sold 12,855 shares of the company’s stock in a transaction that occurred on Monday, December 14th. The stock was sold at an average price of $6.71, for a total transaction of $86,257.05. Following the sale, the insider now directly owns 284,128 shares in the company, valued at approximately […]
   Paratek Pharmaceuticals to Report Third Quarter 2020 Financial Results on November 5, 2020  2020/10/27 12:00:00 GlobeNewswire
BOSTON, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the…
   Paratek Pharmaceuticals, Inc. to Post FY2021 Earnings of ($1.90) Per Share, SVB Leerink Forecasts (NASDAQ:PRTK)  2020/10/24 04:40:50 Dispatch Tribunal
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) – Stock analysts at SVB Leerink dropped their FY2021 earnings per share (EPS) estimates for Paratek Pharmaceuticals in a research report issued to clients and investors on Tuesday, October 20th. SVB Leerink analyst A. Fadia now forecasts that the specialty pharmaceutical company will earn ($1.90) per share for the year, down […]
   Paratek Pharmaceuticals: Undervalued Antibiotics Play With A Fighting Chance (NASDAQ:PRTK)  2020/09/18 02:39:39 Seeking Alpha
Paratek has developed 2 antibiotics treatments - Nuzyra and Seysara - to treat different types of skin conditions.
   Paratek Pharmaceuticals : Wedbush Conference August 2020 | MarketScreener  2020/08/12 21:43:05 MarketScreener
QIDP … | August 12, 2020
   Earnings Scheduled For August 10, 2020  2020/08/10 08:10:24 Benzinga
Companies Reporting Before The Bell • Acacia Research Inc. (NASDAQ: ACTG ) is expected to report quarterly loss at $0.02 per share on revenue of $200.00 thousand. • Akebia Therapeutics Inc. (NASDAQ: AKBA ) is expected to report quarterly loss at $0.50 per share on revenue of $74.18 million. • Apyx Medical Inc. (NASDAQ: APYX ) is estimated to report quarterly loss at $0.21 per share on revenue of $1.96 million. • Avadel Pharmaceuticals Inc. (NASDAQ: AVDL ) is estimated to report quarterly loss at $0.10 per share on revenue of $7.37 million. • Axsome Therapeutics Inc. (NASDAQ: AXSM ) is estimated to report earnings for its second quarter. • Liberty Braves Group Inc. (NASDAQ: BATRK ) is estimated to report earnings for its second quarter. • Biohaven Pharmaceutical Inc. (NYSE: BHVN ) is expected to report earnings for its second quarter. • Black Knight Inc. (NYSE: BKI ) is expected to report quarterly earnings at $0.47 per share on revenue of $290.66 million. • Bluerock Residential Growth REIT, Inc.
   Paratek Pharmaceuticals to Report Third Quarter 2020 Financial Results on November 5, 2020  2020/10/27 12:00:00 GlobeNewswire
BOSTON, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the…
   Paratek Pharmaceuticals, Inc. to Post FY2021 Earnings of ($1.90) Per Share, SVB Leerink Forecasts (NASDAQ:PRTK)  2020/10/24 04:40:50 Dispatch Tribunal
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) – Stock analysts at SVB Leerink dropped their FY2021 earnings per share (EPS) estimates for Paratek Pharmaceuticals in a research report issued to clients and investors on Tuesday, October 20th. SVB Leerink analyst A. Fadia now forecasts that the specialty pharmaceutical company will earn ($1.90) per share for the year, down […]
   Paratek Pharmaceuticals: Undervalued Antibiotics Play With A Fighting Chance (NASDAQ:PRTK)  2020/09/18 02:39:39 Seeking Alpha
Paratek has developed 2 antibiotics treatments - Nuzyra and Seysara - to treat different types of skin conditions.
   Paratek Pharmaceuticals : Wedbush Conference August 2020 | MarketScreener  2020/08/12 21:43:05 MarketScreener
QIDP … | August 12, 2020
   Earnings Scheduled For August 10, 2020  2020/08/10 08:10:24 Benzinga
Companies Reporting Before The Bell • Acacia Research Inc. (NASDAQ: ACTG ) is expected to report quarterly loss at $0.02 per share on revenue of $200.00 thousand. • Akebia Therapeutics Inc. (NASDAQ: AKBA ) is expected to report quarterly loss at $0.50 per share on revenue of $74.18 million. • Apyx Medical Inc. (NASDAQ: APYX ) is estimated to report quarterly loss at $0.21 per share on revenue of $1.96 million. • Avadel Pharmaceuticals Inc. (NASDAQ: AVDL ) is estimated to report quarterly loss at $0.10 per share on revenue of $7.37 million. • Axsome Therapeutics Inc. (NASDAQ: AXSM ) is estimated to report earnings for its second quarter. • Liberty Braves Group Inc. (NASDAQ: BATRK ) is estimated to report earnings for its second quarter. • Biohaven Pharmaceutical Inc. (NYSE: BHVN ) is expected to report earnings for its second quarter. • Black Knight Inc. (NYSE: BKI ) is expected to report quarterly earnings at $0.47 per share on revenue of $290.66 million. • Bluerock Residential Growth REIT, Inc.

calendar